These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 27583352)
61. The 8-oxoguanine DNA N-glycosylase 1 (hOGG1) Ser326Cys variant affects the susceptibility to Graves' disease. Tanrikulu S; Doğru-Abbasoğlu S; Ozderya A; Ademoğlu E; Karadağ B; Erbil Y; Uysal M Cell Biochem Funct; 2011 Apr; 29(3):244-8. PubMed ID: 21465496 [TBL] [Abstract][Full Text] [Related]
62. hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type. Okasaka T; Matsuo K; Suzuki T; Ito H; Hosono S; Kawase T; Watanabe M; Yatabe Y; Hida T; Mitsudomi T; Tanaka H; Yokoi K; Tajima K J Hum Genet; 2009 Dec; 54(12):739-45. PubMed ID: 19881468 [TBL] [Abstract][Full Text] [Related]
63. Lung Cancer Susceptibility and hOGG1 Ser326Cys Polymorphism: A Meta-Analysis. Kiyohara C; Takayama K; Nakanishi Y Cancers (Basel); 2010 Oct; 2(4):1813-29. PubMed ID: 24281202 [TBL] [Abstract][Full Text] [Related]
64. Xia Y; Wang W; Wang L; Shen S; Cao Y; Yi L; Gao Q; Wang Y Biomed Rep; 2016 Apr; 4(4):421-426. PubMed ID: 27073625 [TBL] [Abstract][Full Text] [Related]
65. Cumulative meta-analysis and trial sequential analysis of correlation between hOGG1 Ser326Cys polymorphism and the risk of head and neck squamous cell carcinoma. Yan Y; Deng AP; Chen W; Ming YH; Zeng XT; Leng WD Oncotarget; 2018 Feb; 9(16):13077-13087. PubMed ID: 29560133 [TBL] [Abstract][Full Text] [Related]
66. Association between the OGG1 Ser326Cys Polymorphism and Cancer Risk: Evidence from 152 Case-Control Studies. Zou H; Li Q; Xia W; Liu Y; Wei X; Wang D J Cancer; 2016; 7(10):1273-80. PubMed ID: 27390603 [TBL] [Abstract][Full Text] [Related]
67. Structural and Functional Analysis of human lung cancer risk associated hOGG1 variant Ser326Cys in DNA repair gene by molecular dynamics simulation. Abduljaleel Z Noncoding RNA Res; 2019 Sep; 4(3):109-119. PubMed ID: 31891019 [TBL] [Abstract][Full Text] [Related]
68. TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population. Yang X; Li P; Yang X; Qin C; Cao Q; Zhang Z; Wang M; Cai H; Gu J; Tao J; Gu M; Lu Q; Yin C Int J Genomics; 2013; 2013():473242. PubMed ID: 24367787 [TBL] [Abstract][Full Text] [Related]
69. Associations between hOGG1 sequence variants and prostate cancer susceptibility. Walsh PC J Urol; 2002 Oct; 168(4 Pt 1):1636. PubMed ID: 12356046 [No Abstract] [Full Text] [Related]
70. Retraction of "XRCC1 and hOGG1 polymorphisms and endometrial carcinoma: A meta-analysis". He S; Zhao X; Mu R; Pan Z; Mai J Open Med (Wars); 2024; 19(1):20241000. PubMed ID: 38947216 [TBL] [Abstract][Full Text] [Related]
71. OGG1 DNA Repair Gene Polymorphism As a Biomarker of Oxidative and Genotoxic DNA Damage. Miglani K; Kumar S; Yadav A; Aggarwal N; Gupta R Iran Biomed J; 2021 Jan; 25(1):47-53. PubMed ID: 33129239 [TBL] [Abstract][Full Text] [Related]
73. The hOGG1 Ser326Cys polymorphism and esophageal cancer risk: a meta-analysis of 1,875 cancer cases and 3,041 controls. Zhao C; Yang J; Xu L Ann Transl Med; 2019 Sep; 7(18):438. PubMed ID: 31700874 [TBL] [Abstract][Full Text] [Related]
74. Correlation analysis of mRNA expression and prognosis of hOGG1 gene polymorphism in patients with non-small cell lung cancer. Wang J; Wu P Oncol Lett; 2019 Sep; 18(3):2310-2315. PubMed ID: 31402936 [TBL] [Abstract][Full Text] [Related]
75. DNA repair genes polymorphisms and genetic susceptibility to Philadelphia-negative myeloproliferative neoplasms in a Portuguese population: The role of base excision repair genes polymorphisms. Azevedo AP; Silva SN; De Lima JP; Reichert A; Lima F; Júnior E; Rueff J Oncol Lett; 2017 Jun; 13(6):4641-4650. PubMed ID: 28599464 [TBL] [Abstract][Full Text] [Related]
76. The hOGG1 Ser326Cys gene polymorphism and susceptibility for bladder cancer: a meta-analysis. Wenjuan C; Jianzhong L; Chong L; Yanjun G; Keqing L; Hanzhang W; Zhiping W Int Braz J Urol; 2016; 42(5):883-896. PubMed ID: 27583352 [TBL] [Abstract][Full Text] [Related]
77. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis. Li D; Liu H; Yan L; Tang Y; Ren J; Xu Z Urol Int; 2012; 88(1):88-94. PubMed ID: 22156293 [TBL] [Abstract][Full Text] [Related]
78. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis. Yuan W; Xu L; Feng Y; Yang Y; Chen W; Wang J; Pang D; Li D Breast Cancer Res Treat; 2010 Aug; 122(3):835-42. PubMed ID: 20058067 [TBL] [Abstract][Full Text] [Related]
79. An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis. Ji C; Liu Z; Chen H; Guo H; Liu C BMC Cancer; 2012 Aug; 12():335. PubMed ID: 22857644 [TBL] [Abstract][Full Text] [Related]